Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chinese Government Takes First Steps To De-link Indigenous Innovation And Procurement, But Industry Groups Wary

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Months after pledging a policy change, China is finally taking steps to break ties between indigenous innovation and government procurement policies. The changes in policy, according to a report released by the U.S.-China Business Council, address growing concern among multinationals that procurement policies - an estimated $1 trillion market - are increasingly designed to shut them out
Advertisement

Related Content

Rising Labor Cost Top Risk For Multinationals In China – AmCham Survey
A Weak Link: Chinese Courts Reluctant To Grant Preliminary Injunctions In Pharma IP Cases
A Weak Link: Chinese Courts Reluctant To Grant Preliminary Injunctions In Pharma IP Cases
China Joins U.S. In Common Application Format To Simplify Patent Applications
Headway Seen In EU-India FTA Talks, Commerce Ministry Joint Secretary Says
AdvaMed Lobbies Chinese Government Ahead Of Expected Price Cuts
Sweating The Little Things: European Companies Call On China to Overhaul Public Procurement System
Chinese President Pledges China Will Not Discriminate Against U.S. Businesses; Broad Healthcare Partnership Unveiled
Chinese President Pledges China Will Not Discriminate Against U.S. Businesses; Broad Healthcare Partnership Unveiled
Advertisement
UsernamePublicRestriction

Register

SC078770

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel